Suppr超能文献

按性别、吸烟状况和种族划分的非小细胞肺癌患者体重指数与总生存率的关系:对20937名国际肺癌协会(ILCCO)患者的汇总分析

The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.

作者信息

Jiang Mei, Fares Aline F, Shepshelovich Daniel, Yang Ping, Christiani David, Zhang Jie, Shiraishi Kouya, Ryan Brid M, Chen Chu, Schwartz Ann G, Tardon Adonina, Shete Sanjay, Schabath Matthew B, Teare M Dawn, Le Marchand Loic, Zhang Zuo-Feng, Field John K, Brenner Hermann, Diao Nancy, Xie Juntao, Kohno Takashi, Harris Curtis C, Wenzlaff Angela S, Fernandez-Tardon Guillermo, Ye Yuanqing, Taylor Fiona, Wilkens Lynne R, Davies Michael, Liu Yi, Barnett Matt J, Goodman Gary E, Morgenstern Hal, Holleczek Bernd, Thomas Sera, Brown M Catherine, Hung Rayjean J, Xu Wei, Liu Geoffrey

机构信息

Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada; Hospital de Base, São José do Rio Preto, São Paulo, Brazil.

出版信息

Lung Cancer. 2021 Feb;152:58-65. doi: 10.1016/j.lungcan.2020.11.029. Epub 2020 Dec 4.

Abstract

INTRODUCTION

The relationship between Body-Mass-Index (BMI) and lung cancer prognosis is heterogeneous. We evaluated the impact of sex, smoking and race on the relationship between BMI and overall survival (OS) in non-small-cell-lung-cancer (NSCLC).

METHODS

Data from 16 individual ILCCO studies were pooled to assess interactions between BMI and the following factors on OS: self-reported race, smoking status and sex, using Cox models (adjusted hazard ratios; aHR) with interaction terms and adjusted penalized smoothing spline plots in stratified analyses.

RESULTS

Among 20,937 NSCLC patients with BMI values, females = 47 %; never-smokers = 14 %; White-patients = 76 %. BMI showed differential survival according to race whereby compared to normal-BMI patients, being underweight was associated with poor survival among white patients (OS, aHR = 1.66) but not among black patients (aHR = 1.06; p = 0.02). Comparing overweight/obese to normal weight patients, Black NSCLC patients who were overweight/obese also had relatively better OS (p = 0.06) when compared to White-patients. BMI was least associated with survival in Asian-patients and never-smokers. The outcomes of female ever-smokers at the extremes of BMI were associated with worse outcomes in both the underweight (p<0.001) and obese categories (p = 0.004) relative to the normal-BMI category, when compared to male ever-smokers.

CONCLUSION

Underweight and obese female ever-smokers were associated with worse outcomes in White-patients. These BMI associations were not observed in Asian-patients and never-smokers. Black-patients had more favorable outcomes in the extremes of BMI when compared to White-patients. Body composition in Black-patients, and NSCLC subtypes more commonly seen in Asian-patients and never-smokers, may account for differences in these BMI-OS relationships.

摘要

引言

体重指数(BMI)与肺癌预后之间的关系是异质性的。我们评估了性别、吸烟和种族对非小细胞肺癌(NSCLC)患者BMI与总生存期(OS)关系的影响。

方法

汇总来自16项ILCCO个体研究的数据,使用带有交互项的Cox模型(调整后风险比;aHR)和分层分析中的调整惩罚平滑样条图,评估BMI与以下因素对OS的交互作用:自我报告的种族、吸烟状况和性别。

结果

在20937例有BMI值的NSCLC患者中,女性占47%;从不吸烟者占14%;白人患者占76%。BMI显示出因种族而异的生存期差异,与正常BMI患者相比,体重过轻与白人患者的生存期较差相关(OS,aHR = 1.66),但与黑人患者无关(aHR = 1.06;p = 0.02)。与正常体重患者相比,超重/肥胖的黑人NSCLC患者的OS也相对较好(p = 0.06)。BMI与亚洲患者和从不吸烟者的生存期关联最小。与男性曾经吸烟者相比,BMI处于极端值的女性曾经吸烟者在体重过轻(p<0.001)和肥胖类别(p = 0.004)中的结局均比正常BMI类别更差。

结论

体重过轻和肥胖的女性曾经吸烟者与白人患者较差的结局相关。在亚洲患者和从不吸烟者中未观察到这些BMI关联。与白人患者相比,黑人患者在BMI极端值时的结局更有利。黑人患者的身体组成以及亚洲患者和从不吸烟者中更常见的NSCLC亚型可能解释了这些BMI与OS关系的差异。

相似文献

3
[Body mass index and cancer incidence:a prospective cohort study in northern China].
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6.
4
Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Chin J Cancer. 2017 Jan 10;36(1):7. doi: 10.1186/s40880-016-0170-7.
8
BMI-mortality association: shape independent of smoking status but different for chronic lung disease and lung cancer.
Int J Chron Obstruct Pulmon Dis. 2018 Jun 6;13:1851-1855. doi: 10.2147/COPD.S157629. eCollection 2018.

引用本文的文献

1
Inverse Association of Longitudinal Variations in Fat Tissue Radiodensity and Area.
Diagnostics (Basel). 2025 Jun 30;15(13):1662. doi: 10.3390/diagnostics15131662.
2
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI.
Nat Commun. 2025 Jul 1;16(1):5608. doi: 10.1038/s41467-025-60730-4.
5
Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non-Small Cell Lung Cancer: Obesity, Gender, and TME in NSCLC.
Ann Thorac Surg Short Rep. 2023 Sep;1(3):465-468. doi: 10.1016/j.atssr.2023.05.012. Epub 2023 Aug 31.
6
Lung cancer and obesity: A contentious relationship (Review).
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8817. Epub 2024 Nov 4.
8
Geographical Disparities in Lung Cancer in Canada: A Review.
Curr Oncol Rep. 2024 Mar;26(3):221-235. doi: 10.1007/s11912-024-01499-5. Epub 2024 Feb 6.

本文引用的文献

1
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
Ann Oncol. 2018 Feb;29 Suppl 2:ii1-ii9. doi: 10.1093/annonc/mdx810. Epub 2019 Dec 4.
2
Sex and survival in non-small cell lung cancer: A nationwide cohort study.
PLoS One. 2019 Jun 27;14(6):e0219206. doi: 10.1371/journal.pone.0219206. eCollection 2019.
5
Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis.
Chest. 2019 Jul;156(1):101-111. doi: 10.1016/j.chest.2019.04.115. Epub 2019 May 22.
6
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):782-793. doi: 10.1002/jcsm.12418. Epub 2019 Apr 1.
7
The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers.
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1200-1208. doi: 10.1002/jcsm.12379. Epub 2019 Jan 13.
8
The obese adipose tissue microenvironment in cancer development and progression.
Nat Rev Endocrinol. 2019 Mar;15(3):139-154. doi: 10.1038/s41574-018-0126-x.
9
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.
Nat Rev Endocrinol. 2018 Sep;14(9):513-537. doi: 10.1038/s41574-018-0062-9.
10
Sex differences in body composition and association with cardiometabolic risk.
Biol Sex Differ. 2018 Jun 27;9(1):28. doi: 10.1186/s13293-018-0189-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验